Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry
- PMID: 36924015
- DOI: 10.1002/ccd.30627
Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry
Abstract
Background: With expansion of transcatheter aortic valve implantation (TAVI) into younger patients, valve durability is critically important.
Aims: We aimed to evaluate long-term valve function and incidence of severe structural valve deterioration (SVD) among patients ≥ 10-years post-TAVI and with echocardiographic follow-up at least 5-years postprocedure.
Methods: Data on patients who underwent TAVI from 2007 to 2011 were obtained from the UK TAVI registry. Patients with paired echocardiograms postprocedure and ≥5-years post-TAVI were included. Severe SVD was determined according to European task force guidelines.
Results: 221 patients (79.4 ± 7.3 years; 53% male) were included with median echocardiographic follow-up 7.0 years (range 5-13 years). Follow-up exceeded 10 years in 43 patients (19.5%). Valve types were the supra-annular self-expanding CoreValve (SEV; n = 143, 67%), balloon-expandable SAPIEN/XT (BEV; n = 67, 31%), Portico (n = 4, 5%) and unknown (n = 7, 3%). There was no difference between postprocedure and follow-up peak gradient in the overall cohort (19.3 vs. 18.4 mmHg; p = NS) or in those with ≥10-years follow-up (21.1 vs. 21.1 mmHg; p = NS). Severe SVD occurred in 13 patients (5.9%; median 7.8-years post-TAVI). Three cases (23.1%) were due to regurgitation and 10 (76.9%) to stenosis. Valve-related reintervention/death occurred in 5 patients (2.3%). Severe SVD was more frequent with BEV than SEV (11.9% vs. 3.5%; p = 0.02), driven by a difference in patients treated with small valves (BEV 28.6% vs. SEV 3.0%; p < 0.01).
Conclusions: Hemodynamic function of transcatheter heart valves remains stable up to more than 10 years post-TAVI. Severe SVD occurred in 5.9%, and valve-related death/reintervention in 2.3%. Severe SVD was more common with BEV than SEV.
Keywords: structural valve deterioration; transcatheter aortic valve replacement; valve durability.
© 2023 Wiley Periodicals LLC.
Comment in
-
TAVR for all-Is it time?Catheter Cardiovasc Interv. 2023 May;101(6):1174-1175. doi: 10.1002/ccd.30665. Epub 2023 Apr 25. Catheter Cardiovasc Interv. 2023. PMID: 37096934 No abstract available.
References
REFERENCES
-
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical Aortic-Valve replacement in High-Risk patients. N Engl J Med. 2011;364(23):2187-2198.
-
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
-
- Adams DH, Popma JJ, Reardon MJ, et al.Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-1798.
-
- Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients With severe aortic valve stenosis. JACC. 2015;65(20):2184-2194.
-
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609-1620.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
